Acetylcholinesterase inhibitors (AChEIs) are a mainstay in Alzheimer’s disease treatment, as they enhance cholinergic transmission and cognitive function [103]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.